Financhill
Buy
55

SNDX Quote, Financials, Valuation and Earnings

Last price:
$21.62
Seasonality move :
13.43%
Day range:
$21.46 - $22.73
52-week range:
$8.58 - $22.73
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
16.77x
P/B ratio:
16.34x
Volume:
1.5M
Avg. volume:
2.1M
1-year change:
63.04%
Market cap:
$1.9B
Revenue:
$23.7M
EPS (TTM):
-$3.62

Earnings Data

Next earnings date for SNDX
Mar 02
2026
Most recent earnings per share
-$0.70
Beat by $0.01
(Nov 3/2025)
Consensus Estimate
-$0.71
(Nov 3/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SNDX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/02/2026 Q4 $64.1M -- -- -$0.58 --
11/03/2025 Q3 $48M $45.9M -$0.70 -$0.71 $0.01
08/04/2025 Q2 $26.6M $38M -$0.83 -$1.01 $0.17
05/05/2025 Q1 $16.2M $20M -$0.98 -$1.27 $0.29
03/03/2025 Q4 $86.5M $7.7M -$1.10 -$0.23 -$0.87
11/05/2024 Q3 $8.4M $12.5M -$0.98 -$1.06 $0.08
08/01/2024 Q2 -- $3.5M -$0.80 -$0.91 $0.11
05/08/2024 Q1 -- -- -$0.85 -$0.99 $0.14
02/27/2024 Q4 -- -- -$1.00 -$0.97 -$0.03
11/02/2023 Q3 -- -- -$0.73 -- --
08/03/2023 Q2 -- -- -$0.64 -- --
05/08/2023 Q1 -- -- -$0.59 -- --
02/28/2023 Q4 -- -- -$0.62 -- --
11/03/2022 Q3 -- -- -$0.58 -- --
08/08/2022 Q2 -- -- -$0.62 -- --
05/09/2022 Q1 -- -- -$0.63 -- --
03/01/2022 Q4 -- $126.6M $1.84 -- --
11/15/2021 Q3 -- $12.4M -$0.40 -- --
08/09/2021 Q2 -- $379K -$0.44 -- --
05/11/2021 Q1 -- $379K -$0.54 -- --
03/08/2021 Q4 -- $380K -$0.44 -- --
11/02/2020 Q3 -- $379K -$0.46 -- --
08/06/2020 Q2 -- $379K -$0.42 -- --
05/07/2020 Q1 -- $379K -$0.56 -- --
03/03/2020 Q4 -- $380K -$0.44 -- --
11/07/2019 Q3 -- $379K -$0.41 -- --
08/07/2019 Q2 -- $379K -$0.47 -- --
05/06/2019 Q1 -- $379K -$0.53 -- --
03/07/2019 Q4 -- $380K -$0.70 -- --
11/05/2018 Q3 -- $379K -$0.68 -- --
08/07/2018 Q2 -- $379K -$0.74 -- --
05/08/2018 Q1 -- $379K -$0.79 -- --
03/05/2018 Q4 -- $1.2M -$0.80 -- --
11/07/2017 Q3 -- $305K -$0.68 -- --
08/10/2017 Q2 -- $305K -$0.70 -- --
05/08/2017 Q1 -- $305K -$0.71 -- --
03/02/2017 Q4 -- $305K -$0.59 -- --
11/10/2016 Q3 -- $305K -$0.84 -- --
08/09/2016 Q2 -- $305K -$0.47 -- --
05/16/2016 Q1 -- $305K -$2.85 -- --
12/31/2015 Q4 -- -- -$0.51 -- --

Syndax Pharmaceuticals, Inc. Earnings Questions

  • How Much did Syndax Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Syndax Pharmaceuticals, Inc. reported $45.9M worth of top line sales in its most recent quarter.

  • Did Syndax Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Syndax Pharmaceuticals, Inc. announced earnings per share of -$0.70 which represents a beat of analyst forecast a -$0.71 per share.

  • Is Syndax Pharmaceuticals, Inc. Profitable?

    Syndax Pharmaceuticals, Inc. reported $43.8M that represents $0.51 per share over the last quarter.

  • What is the Analyst Consensus for Syndax Pharmaceuticals, Inc. EPS Next Year?

    Syndax Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$3.72 per share to -$2.80 per share next year representing a decrease of -18.02%.

  • When is Syndax Pharmaceuticals, Inc.'s Earnings Date?

    Syndax Pharmaceuticals, Inc.'s next earnings date is March 2, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Is Bloom Energy The Best Stock to Buy Now?
Is Bloom Energy The Best Stock to Buy Now?

Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 3.24% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 1.39% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock